- Home
- IINN vs PLUR Comparison
IINN vs PLUR Comparison
Compare IINN & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- PLUR
- Stock Information
- Founded
- IINN 2018
- PLUR 2001
- Country
- IINN Israel
- PLUR Israel
- Employees
- IINN N/A
- PLUR N/A
- Industry
- IINN Medical/Dental Instruments
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IINN Health Care
- PLUR Health Care
- Exchange
- IINN Nasdaq
- PLUR Nasdaq
- Market Cap
- IINN 32.4M
- PLUR 36.9M
- IPO Year
- IINN 2021
- PLUR N/A
- Fundamental
- Price
- IINN $0.88
- PLUR $3.55
- Analyst Decision
- IINN Strong Buy
- PLUR Strong Buy
- Analyst Count
- IINN 1
- PLUR 1
- Target Price
- IINN $2.00
- PLUR $12.00
- AVG Volume (30 Days)
- IINN 252.0K
- PLUR 9.2K
- Earning Date
- IINN 10-01-2025
- PLUR 11-11-2025
- Dividend Yield
- IINN N/A
- PLUR N/A
- EPS Growth
- IINN N/A
- PLUR N/A
- EPS
- IINN N/A
- PLUR N/A
- Revenue
- IINN $289,000.00
- PLUR $1,336,000.00
- Revenue This Year
- IINN N/A
- PLUR $97.38
- Revenue Next Year
- IINN $2,582.74
- PLUR $293.97
- P/E Ratio
- IINN N/A
- PLUR N/A
- Revenue Growth
- IINN N/A
- PLUR 309.82
- 52 Week Low
- IINN $0.40
- PLUR $3.33
- 52 Week High
- IINN $1.65
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- IINN 26.17
- PLUR 34.50
- Support Level
- IINN $1.01
- PLUR $3.60
- Resistance Level
- IINN $0.96
- PLUR $4.00
- Average True Range (ATR)
- IINN 0.06
- PLUR 0.18
- MACD
- IINN -0.02
- PLUR -0.03
- Stochastic Oscillator
- IINN 8.94
- PLUR 1.24
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.